Healthy high growth potential

Results

1481

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1481 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
6223
NT$7,255.005.1%611.3%NT$710.9bNT$7,502.73193.255.5%0.3%Semiconductors
AGP
€7.141.6%-6.9%€130.2m€8.5726.237.8%n/aCapital Goods
CDR
zł232.504.1%-13.7%zł23.2bzł235.1345.029.7%0.4%Media
KEBNI B
SEK 1.04-15.8%-48.8%SEK 283.9mSEK 1.602.582.7%n/aTech
CORT
US$90.216.4%24.8%US$9.5bUS$88.00207.548.9%n/aPharmaceuticals & Biotech
FWRY
ج.م18.40-1.6%50.8%ج.م62.7bج.م22.4523.627.3%n/aDiversified Financials
AXSM
US$244.311.1%131.7%US$12.6bUS$276.4717.857.4%n/aPharmaceuticals & Biotech
SAUD3
R$14.410.9%22.8%R$42.1bR$16.2174.641.6%5.6%Healthcare
688072
CN¥832.000%425.9%CN¥234.1bCN¥511.08142.435.2%0.04%Semiconductors
7769
NT$6,850.005.4%443.7%NT$1.3tNT$9,322.7185.543.7%0.9%Semiconductors
2368
NT$1,300.009.2%332.6%NT$624.1bNT$1,485.0058.038.2%0.8%Tech
6787
JP¥29,470.00-2.6%326.5%JP¥733.6bJP¥26,066.6738.927.3%0.5%Tech
9218
JP¥729.003.6%12.8%JP¥7.7bn/a32.228.9%1.4%Healthcare
MDGL
US$528.103.0%76.7%US$12.2bUS$678.7110.859.2%n/aPharmaceuticals & Biotech
RHM
€1,115.0017.8%-34.4%€50.1b€1,763.8549.430.7%1.0%Capital Goods
CRDO
US$241.911.6%158.4%US$45.1bUS$269.8195.527.5%n/aSemiconductors
LITE
US$728.32-10.9%685.3%US$56.7bUS$1,111.29129.179.1%n/aTech
NVDA
US$194.83-0.5%22.3%US$4.8tUS$301.6229.622.2%0.5%Semiconductors
MOD
US$230.97-18.6%120.9%US$12.9bUS$340.86100.449.3%n/aCapital Goods
605376
CN¥238.10-9.8%528.6%CN¥64.4bCN¥120.50256.445.7%0.04%Materials
300432
CN¥20.185.7%58.6%CN¥33.6bCN¥34.4068.160.7%0.5%Automobiles
7685
JP¥3,560.005.3%149.8%JP¥211.8bJP¥4,666.6729.925.5%0.6%Retail
4417
JP¥4,175.0026.1%40.1%JP¥60.6bJP¥4,500.0042.224.1%0.8%Software
002384
CN¥232.73-10.6%446.3%CN¥404.1bCN¥157.50207.973.1%0%Tech
Page 1 of 42